Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania is a technology-focused capital provider based in Philadelphia, founded in 1982 to advance the region's technology community. The organization funds and supports technology companies across Pennsylvania, especially in information technology, health, and physical sciences, investing substantial capital in early-stage and established ventures. It has invested over 170 million dollars in more than 1,750 regional technology companies and has launched university-industry partnerships to translate scientific discoveries into commercial products, while seeding regional initiatives that strengthen the entrepreneurial ecosystem and create jobs.

Jonathan Beschen

Investment Director, Information Technology Investment Group

Anthony George

Analyst

Jennifer Hartt

Managing Director

Kathie Jordan Ph.D

Managing Director, Healthcare Investment Group

Roze McDevitt

Analyst

Adare McMillan

CFO

Omar Mencin

Managing Director

Scott Nissenbaum

President

Aston Pierce

Investor

Mark de Grandpre

Investor

Past deals in Maryland

Houwzer

Seed Round in 2017
Founded in 2015, Houwzer is a real estate brokerage company that prioritizes customer service. It offers full-service, salaried agents who focus on providing exceptional service rather than earning commissions. The company's proprietary technology platform streamlines the entire home buying and selling process, saving customers time and money. Houwzer has maintained an industry-leading Net Promoter Score of 84 and an average rating of 4.9 out of 5 stars from hundreds of client reviews.

Corridor Pharmaceuticals

Series A in 2010
Corridor Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutic small molecule inhibitors of arginase. Its arginase is an enzyme that competes with endothelial nitric oxide synthase for the use of the common substrate l-arginine. The company's arginase also leads to the production of ornithine which increases polyamine, stimulating cell division, and contributing to hyperplasia and fibrosis. Corridor Pharmaceuticals, Inc. was formerly known as Arginetix, Inc. and changed its name to Corridor Pharmaceuticals, Inc. on June 17, 2010. The company was founded in 2007 and is based in Lutherville, Maryland.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.